| Cell‐free protein expression based on extracts from CHO cells AK Brödel, A Sonnabend, S Kubick Biotechnology and bioengineering 111 (1), 25-36, 2014 | 163 | 2014 |
| IRES-mediated translation of membrane proteins and glycoproteins in eukaryotic cell-free systems AK Brödel, A Sonnabend, LO Roberts, M Stech, DA Wüstenhagen, ... PloS one 8 (12), e82234, 2013 | 98 | 2013 |
| Engineering orthogonal dual transcription factors for multi-input synthetic promoters AK Brödel, A Jaramillo, M Isalan Nature communications 7 (1), 13858, 2016 | 61 | 2016 |
| Cell-free systems: functional modules for synthetic and chemical biology M Stech, AK Brödel, RB Quast, R Sachse, S Kubick Fundamentals and Application of New Bioproduction Systems, 67-102, 2013 | 40 | 2013 |
| Cell-free protein synthesis systems derived from cultured mammalian cells AK Brödel, DA Wüstenhagen, S Kubick Structural Proteomics: High-Throughput Methods, 129-140, 2015 | 35 | 2015 |
| Functional evaluation of candidate ice structuring proteins using cell-free expression systems AK Brödel, JA Raymond, JG Duman, FF Bier, S Kubick Journal of biotechnology 163 (3), 301-310, 2013 | 27 | 2013 |
| Intracellular directed evolution of proteins from combinatorial libraries based on conditional phage replication AK Brödel, A Jaramillo, M Isalan nature protocols 12 (9), 1830-1843, 2017 | 20 | 2017 |
| Engineering of biomolecules by bacteriophage directed evolution AK Brödel, M Isalan, A Jaramillo Current Opinion in Biotechnology 51, 32-38, 2018 | 18 | 2018 |
| Accelerated evolution of a minimal 63–amino acid dual transcription factor AK Brödel, R Rodrigues, A Jaramillo, M Isalan Science Advances 6 (24), eaba2728, 2020 | 16 | 2020 |
| Developing cell-free protein synthesis systems: a focus on mammalian cells AK Brödel, S Kubick Pharmaceutical Bioprocessing 2 (4), 339-348, 2014 | 11 | 2014 |
| Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders X Duportet, A Decrulle, C del Carmen Gil-Cruz, CI Pérez-Shibayama, ... US Patent 11,376,286, 2022 | 8 | 2022 |
| In situ targeted mutagenesis of gut bacteria AK Brödel, L Charpenay, M Galtier, FJ Fuche, R Terrasse, C Poquet, ... bioRxiv, 2022.09. 30.509847, 2022 | 4 | 2022 |
| Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders X Duportet, A Decrulle, C del Carmen Gil-Cruz, CI Pérez-Shibayama, ... US Patent 11,224,621, 2022 | 3 | 2022 |
| Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders X Duportet, A Decrulle, C del Carmen Gil-Cruz, CI Pérez-Shibayama, ... US Patent 11,534,467, 2022 | 2 | 2022 |
| Engineering the smallest transcription factor: accelerated evolution of a 63-amino acid peptide dual activator-repressor AK Brödel, R Rodrigues, A Jaramillo, M Isalan bioRxiv, 725739, 2019 | 2 | 2019 |
| Trp-ing upon new repressors AK Brödel, M Isalan Nature Chemical Biology 14 (4), 328-329, 2018 | 1 | 2018 |
| CCCRYO - Culture collection of cryophilic algae: A bioresource for industrially relevant metabolites T Leya, A Broedel, D Connor, F Jorde, D Wenzel European Journal of Phycology 46 (Supplement 1, Special Issue), 83-84, 2011 | 1 | 2011 |
| Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders X Duportet, A Decrulle, C del Carmen Gil-Cruz, CI Pérez-Shibayama, ... US Patent App. 18/319,158, 2023 | | 2023 |
| Recent patents relating to microbiome classification, modulation and treatment of diseases. GC CdC, CI Pérez-Shibayama, B Ludewig, J Fernandez Rodriguez, ... nature biotechnology 41 (1200), 1200, 2023 | | 2023 |
| Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders X Duportet, A Decrulle, C del Carmen Gil-Cruz, CI Pérez-Shibayama, ... US Patent 11,690,880, 2023 | | 2023 |
